Phosphorus control in peritoneal dialysis patients

Kidney International

Volumn 73, Issue SUPPL. 108, 2008, Pages

  Yavuz, A ^a   Ersoy, F F ^a   Passadakis, P S ^b   Tam, P ^c   Evaggelos, D M ^d   Katopodis, K P ^e   Ozener C ^f   Akcicek F ^g   Camsari T ^h   Ates K ⁱ   Ataman, R ^j   Vlachojannis, G J ^k   Dombros, N A ^d   Utas C ^l   Akpolat, T ^m   Bozfakioglu S ⁿ   Wu, G ^o   Karayaylali, I ^p   Arinsoy, T ^q   Stathakis, C P ^r   Yavuz, M ^s   Tsakiris, D J ^t   Dimitriades, A C ^u   Yilmaz, M E ^v   Gultekin M ^a   Suleymanlar G ^a   Oreopoulos, D G ^w   more..

^a AKDENIZ UNIVERSITY   (Turkey)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c SCARBOROUGH HOSPITAL   (Canada)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^f MARMARA UNIVERSITY   (Turkey)

^g EGE UNIVERSITY   (Turkey)

^h DOKUZ EYLUL UNIVERSITY   (Turkey)

ⁱ ANKARA UNIVERSITY   (Turkey)

^j ISTANBUL UNIVERSITY   (Turkey)

^k UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^l ERCIYES UNIVERSITY   (Turkey)

^m ONDOKUZ MAYIS UNIVERSITY   (Turkey)

ⁿ ISTANBUL UNIVERSITY   (Turkey)

^o CREDIT VALLEY HOSPITAL   (Canada)

^p CUKUROVA UNIVERSITY   (Turkey)

^q GAZI UNIVERSITY   (Turkey)

^r LAIKO GENERAL HOSPITAL   (Greece)

^s ULUDAG UNIVERSITY   (Turkey)

^t GENERAL HOSPITAL OF VERIA   (Greece)

^u Agios Dimitrios Hospital   (Greece)

^v DICLE UNIVERSITY   (Turkey)

^w TORONTO WESTERN HOSPITAL   (Canada)

more..

Author keywords

Calcium; Dialysis; Peritoneal dialysis; Phosphate binders; Phosphorus; Phosphorus control; Renal osteodystrophy

Indexed keywords

ALKALINE PHOSPHATASE; CALCIFEDIOL; CALCITRIOL; CALCIUM; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS; SERUM ALBUMIN; CREATININE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CANADA; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; GREECE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; TREATMENT DURATION; TURKEY (BIRD); URINE VOLUME; VITAMIN BLOOD LEVEL; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; HYPERPHOSPHATEMIA; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; AGED; ALKALINE PHOSPHATASE; BIOLOGICAL TRANSPORT; CALCIUM; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PERITONEAL DIALYSIS; PHOSPHORUS;

EID: 44449114875     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002617     Document Type: Article

References (36)

1. Block GA, Hulbert-Shearon TE, Levin NW et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617.
2. Taniwaki H et al. Aortic calcification in haemodialysis patients with diabetes mellitus. Nephrol Dial Transplant 2005; 11: 2472-2478.
3. Neves KR, Graciolli FG, dos Reis LM et al. Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int 2007; 71: 1262-1270.
4. Alfrey AC. The role of abnormal phosphorus metabolism in the progression of chronic kidney disease and metastatic calcification. Kidney Int 2004; 90: S13-S17.
5. Rufino M, de Bonis E, Martin M et al. Is it possible to control hyperphosphatemia with diet, without inducing protein malnutrition? Nephrol Dial Transplant 1998; 13: 65-67.
6. Qunibi WY, Nolan CR. Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: results of the CARE study. Kidney Int 2004; 66: S33-S38.
7. Musci I, Hercz G, Uldall R et al. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 1998; 53: 1399-1404.
8. Ayus JC, Achinger SG, Mizani MR et al. Phosphorus balance and mineral metabolism with 3 h daily hemodialysis. Kidney In 2007; 71: 336-342.
9. Jean G, Chazot C, Charra B. Hyperphosphatemia and related mortality. Nephrol Dial Transplant 2006; 21: 273-280.
10. Achinger SG, Ayus JC. The role of daily dialysis in the control of hyperphosphatemia. Kidney Int 2005; 67: S28-S32.
11. Young EW, Albert JM, Satayathum S et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005; 67: 1179-1187.
12. Winchester JF, Rotellar C, Goggins M et al. Calcium and phosphate balance in dialysis patients. Kidney Int 1993; 41: S174-S178.
13. Wang AY, Woo J, Sea MM et al. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications? Am J Kidney Dis 2004; 43: 712-720.
14. Bugg NC, Jones JA. Hypophosphatemia: pathophysiology, effects and management on intensive care unit. Anaesthesia 1998; 53: 895-902.
15. Stoff JC. Phosphate homeostasis and hypophosphatemia. Am J Med 1982; 72: 489-495.
16. Eknoyan G, Levin A, Levin NW. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: 1-201.
17. Sugarman JR, Frederick PR, Frankenfield DL et al. Developing clinical performance measures based on the Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: process, outcomes and implications. Am J Kidney Dis 2003; 42: 806-812.
18. Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 2005; 16: 1788-1793.
19. Young EW, Akiba T, Albert JM et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44: 34-38.
20. Chandna SM, Farrington K. Residual renal function: considerations on its importance and preservation in dialysis patients. Semin Dial 2004; 17: 196-201.
21. Nakamoto H, Imai H, Kawanishi H et al. Low serum albumin in elderly continuous ambulatory peritoneal dialysis patients is attributable to high permeability of peritoneum. Adv Perit Dial 2001; 17: 238-243.
22. Koo JR, Yoon JW, Kim SG et al. Association of depression with malnutrition in chronic hemodialysis patients. Am J Kidney Dis 2003; 41: 1037-1042.
23. Marcen R, Teruel JL, de la Cal MA et al. The impact of malnutrition in morbidity and mortality in stable hemodialysis patients. Spanish Cooperative Study of Nutrition in Hemodialysis. Nephrol Dial Transplant 1997; 12: 2324-2331.
24. Martin KJ, Gonzalez EA. Metabolic bone disease in chronic kidney disease. J Am Soc Nephrol 2007; 18: 875-885.
25. Sawaya BP, Butros R, Naqvi S et al. Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease. Kidney Int 2003; 64: 737-742.
26. Ureña T, Prié D, Molina-Blétry V et al. An antiaging protein involved in mineral and vitamin D metabolism. Kidney Int 2007; 71: 730-737.
27. Morishita K, Shirai A, Kubota M et al. The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc. J Nutr 2001; 131: 3182-3188.
28. Taal MW, Roe S, Masud T et al. Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney Int 2003; 63: 1116-1120.
29. 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138.
30. Wallot M, Bonzel KE, Winter A et al. Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients. Pediatr Nephrol 1996; 10: 625-630.
31. Goodman WG. Perspectives on renal bone disease. Kidney Int 2006; 70: S59-S63.
32. Weinreich T, Passlick-Deetjen J, Ritz E, for the Collaborators of the Peritoneal Dialysis Multicenter Study Group. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. Am J Kidney Dis 1995; 25: 452-460.
33. Sanchez C, Lopez-Barea F, Sanchez-Cabezudo J et al. Low vs standard calcium dialysate in peritoneal dialysis: differences in treatment, biochemistry and bone histomorphometry. A randomized multicentre study. Nephrol Dial Transplant 2004; 19: 1587-1593.
34. Sanchez MC, Bajo MA, Selgas R et al. Parathormone secretion in peritoneal dialysis patients with adynamic bone disease. Am J Kidney Dis 2000; 36: 953-961.
35. Ishimura E, Nishizawa Y, Inaba M et al. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 1999; 55: 1019-1027.
36. Nessim SJ, Jassal SV, Fung SV et al. Conversion from conventional to nocturnal hemodialysis improves vitamin D. Kidney Int 2007; 71: 1172-1176.